Come up with a name for your new list and we'll add to it:
Xalud Therapeutics raised a round of funding on June 25, 2015. Investors include
PBM Capital Group.
Xalud Therapeutics is an IND-stage platform gene therapy company developing novel therapies with several promising therapeutic programs for inflammatory and autoimmune diseases including neuropathic p…